We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals
AMPH

136 hedge funds and large institutions have $489M invested in Amphastar Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 55 increasing their positions, 38 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 38

13% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 15

1% more funds holding

Funds holding: 135 → 136 (+1)

1.88% less ownership

Funds ownership: 57.01% → 55.13% (-1.9%)

17% less capital invested

Capital invested by funds: $591M → $489M (-$102M)

82% less call options, than puts

Call options by funds: $203K | Put options by funds: $1.11M

Holders
136
Holders Change
+1
Holders Change %
+0.74%
% of All Funds
2.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
55
Reduced
38
Closed
15
Calls
$203K
Puts
$1.11M
Net Calls
-$903K
Net Calls Change
+$1.46M

Top Buyers

1
BlackRock
BlackRock
New York
+$5.87M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$3.16M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$2.82M
4
Two Sigma Investments
Two Sigma Investments
New York
+$2.73M
5
Goldman Sachs
Goldman Sachs
New York
+$2.1M

Top Sellers

1
VOYA Investment Management
VOYA Investment Management
Georgia
-$8.38M
2
Nordea Investment Management
Nordea Investment Management
Sweden
-$5.28M
3
Marshall Wace
Marshall Wace
United Kingdom
-$2.97M
4
Renaissance Technologies
Renaissance Technologies
New York
-$2.68M
5
Bessemer Group
Bessemer Group
New Jersey
-$2.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$129M +$5.87M +291,461 +4%
Federated Hermes
2
Federated Hermes
Pennsylvania
$51.4M +$2.82M +140,251 +5%
Vanguard Group
3
Vanguard Group
Pennsylvania
$45.2M +$396K +19,654 +0.8%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$34.2M -$339K -16,829 -0.9%
Invesco
5
Invesco
Georgia
$25.3M +$1.64M +81,540 +6%
State Street
6
State Street
Massachusetts
$24.2M +$610K +30,272 +2%
Fuller & Thaler Asset Management
7
Fuller & Thaler Asset Management
California
$15.3M +$48K +2,386 +0.3%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$10.2M +$35.2K +1,747 +0.3%
Goldman Sachs
9
Goldman Sachs
New York
$10.1M +$2.1M +104,455 +24%
Northern Trust
10
Northern Trust
Illinois
$9.58M -$215K -10,658 -2%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$7.24M +$170K +8,421 +2%
Renaissance Technologies
12
Renaissance Technologies
New York
$7.09M -$2.68M -133,000 -26%
EAM
13
Eagle Asset Management
Florida
$5.29M -$342K -16,974 -6%
SAM
14
Silvercrest Asset Management
New York
$5.27M -$108K -5,340 -2%
Ameriprise
15
Ameriprise
Minnesota
$5M -$507K -25,155 -9%
Nordea Investment Management
16
Nordea Investment Management
Sweden
$4.97M -$5.28M -262,064 -50%
Principal Financial Group
17
Principal Financial Group
Iowa
$4.9M +$194K +9,649 +4%
RCAMU
18
Rothschild & Co Asset Management US
Connecticut
$4.57M -$834K -41,436 -15%
Charles Schwab
19
Charles Schwab
California
$4.45M +$182K +9,031 +4%
Prudential Financial
20
Prudential Financial
New Jersey
$4.28M +$1.61M +79,860 +54%
Wells Fargo
21
Wells Fargo
California
$3.92M -$497K -24,670 -11%
N
22
Nuveen
North Carolina
$3.85M +$416K +20,651 +11%
Two Sigma Investments
23
Two Sigma Investments
New York
$3.54M +$2.73M +135,600 +254%
Jacobs Levy Equity Management
24
Jacobs Levy Equity Management
New Jersey
$3.06M -$214K -10,645 -6%
Two Sigma Advisers
25
Two Sigma Advisers
New York
$2.95M +$3.16M +157,100 New
1
2 3 4 5

AMPH Hedge Fund Activity: Q3 2020 in Review

136 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q3 2020, worth a combined $489M — down 17% from $591M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new AMPH positions and 15 closed out — a net gain of 2 holders — while 55 added to existing stakes and 38 trimmed.

The largest buyer was BlackRock, adding an estimated $5.87M. The largest seller was VOYA Investment Management, cutting an estimated $8.38M.

  • 136 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q3 2020, up from 135 in Q2 2020.
  • Funds reported $489M of Amphastar Pharmaceuticals stock for Q3 2020, down 17% quarter-over-quarter.
  • 17 funds opened new Amphastar Pharmaceuticals positions in Q3 2020 and 15 closed out, a net change of +2 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q3 2020 was BlackRock, an estimated $5.87M added.
  • The largest Amphastar Pharmaceuticals seller in Q3 2020 was VOYA Investment Management, an estimated $8.38M sold.

Based on aggregated 13F filings for Q3 2020.